Review of Late-Breaking Trials From CRT 2021 Virtual.

Authors :: Medranda GA
Case BC
Wermers JP
Morrison N
Waksman R
Source :: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2021 Jul; Vol. 28S, pp. 3-8. Date of Electronic Publication: 2021 Mar 23.
Publication Year :: 2021
Abstract: Competing Interests: Declaration of competing interest Ron Waksman – Advisory Board: Abbott Vascular, Amgen, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd.; Consultant: Abbott Vascular, Amgen, Biotronik, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, Pi-Cardia Ltd., Transmural Systems; Grant Support: AstraZeneca, Biotronik, Boston Scientific, Chiesi; Speakers Bureau: AstraZeneca, Chiesi; Investor: MedAlliance; Transmural Systems. All other authors – None.

Subjects :: Aortic Valve surgery
Humans
Treatment Outcome
Aortic Valve Stenosis surgery
Heart Valve Prosthesis
Percutaneous Coronary Intervention
Transcatheter Aortic Valve Replacement

Language :: English
ISSN :: 1878-0938
Volume :: 28S
Database :: MEDLINE
Journal :: Cardiovascular revascularization medicine : including molecular interventions
Publication Type :: Academic Journal
Accession number :: 33903040
Full Text :: https://doi.org/10.1016/j.carrev.2021.03.016